CTAs keep buying Treasuries, gold longs face stop-loss risk: BofA
Investing.com - J&J reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
J&J announced earnings per share of $2.59 on revenue of $22.32B. Analysts polled by Investing.com EPS of $2.33 on revenue of $22.01B.
J&J 's are up 3% and is trading at $162.69 , still down 6.28% from its 52 week high of $173.59 set on Tuesday, January 26, 2021.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings beat by Signify Health on Wednesday, March 24, 2021, who reported EPS of $0.06 on revenue of $193.5M, EPS of $0.0535 on revenue of $188.94M.
Neogen had missed expectations on Tuesday, March 23, 2021 with third quarter EPS of $0.25 on revenue of $116.71M, for EPS of $0.2567 on revenue of $106.73M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar